NextPharma appoints quality director at Braine-l’Alleud


Brigitte Genard takes responsibility for all aspects of quality at the Belgian plant

NextPharma has appointed Brigitte Genard as quality director at its sterile contract development and manufacturing site in Braine-l’Alleud, Belgium.

Genard takes responsibility for all aspects of quality across the Braine-l’Alleud site, including the FDA- and PDMA-inspected contract manufacturing plant which produces oncology products in commercial quantities and the Sterile Product Development Centre, a centre of excellence for formulation development and manufacture of investigational medicinal products including full lyophilisation capabilities.

Genard is an industrial pharmacist with 18 years of experience in quality assurance and production. She has extensive experience in biopharmaceutical manufacturing and has worked for 15 years in industrial vaccine operations (bulk and secondary). She has also worked for GSK Biologicals and UCB Bioproducts as senior quality assurance manager and head of production.